Source: University of Manchester
Date: 19 June 2007
Summary:
Scientists have created a new stem cell line from a clinically unusable human egg in a development that could have major implications for research into illnesses such as Alzheimer's, Parkinson's, liver disease and diabetes. The breakthrough, by Roslin Cells Ltd, a spin out company established in 2006 by Roslin Institute, and scientists at The University of Manchester, demonstrates for the first time that eggs which are incapable of becoming viable embryos can be used as a source for stem cells. The move could help accelerate the development of regenerative medicine, where there is currently an acute shortage of embryos available for stem cell research.
